{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:28:43Z","timestamp":1791379723575,"version":"4.3.3"},"reference-count":81,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jcehepatology.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jceh.2024.101474","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T16:52:25Z","timestamp":1719334345000},"page":"101474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Redefining HCC Surveillance in India: A Call for Innovative and Inclusive Strategies"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9731-7844","authenticated-orcid":false,"given":"Amit","family":"Yelsangikar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5809-6282","authenticated-orcid":false,"given":"Prachi S.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2024.101474_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jceh.2024.101474_bib2","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.amjmed.2017.01.021","article-title":"Hepatocellular carcinoma screening associated with early tumor detection and improved survival among patients with cirrhosis in the US","volume":"130","author":"Singal","year":"2017","journal-title":"Am J Med"},{"key":"10.1016\/j.jceh.2024.101474_bib3","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/hep.31309","article-title":"Use of hepatocellular carcinoma surveillance in patients with cirrhosis: a systematic review and meta-analysis","volume":"73","author":"Wolf","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101474_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/cncr.33211","article-title":"Patients with hepatocellular carcinoma from more rural and lower-income households have more advanced tumor stage at diagnosis and significantly higher mortality","volume":"127","author":"Wong","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.jceh.2024.101474_bib5","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/hep.27969","article-title":"World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma","volume":"62","author":"de Martel","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101474_bib6","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/j.cgh.2015.08.014","article-title":"Hepatocellular carcinoma from epidemiology to prevention: translating knowledge into practice","volume":"13","author":"Singal","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.101474_bib7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fonc.2020.00171","article-title":"Global trends in incidence rates of primary adult liver cancers: a systematic review and meta-analysis","volume":"10","author":"Dasgupta","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.jceh.2024.101474_bib8","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41575-023-00754-7","article-title":"Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment","volume":"20","author":"Llovet","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.101474_bib9","series-title":"Global Cancer Observatory: Cancer Today","author":"Ferlay","year":"2024"},{"key":"10.1016\/j.jceh.2024.101474_bib10","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.101474_bib11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.31557\/APJCP.2022.23.2.409","article-title":"Descriptive epidemiology of gastrointestinal cancers: results from national cancer registry programme, India","volume":"23","author":"Shakuntala","year":"2022","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.jceh.2024.101474_bib12","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jceh.2021.02.002","article-title":"Experience with changing etiology and nontransplant curative treatment modalities for hepatocellular carcinoma in a real-life setting-a retrospective descriptive analysis","volume":"11","author":"Tohra","year":"2021","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2024.101474_bib13","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jceh.2021.11.006","article-title":"Correlation of clinicopathological profile, prognostic factors, and survival outcomes with baseline alfa-fetoprotein levels in patients with hepatocellular carcinoma: a biomarker that is bruised but not broken","volume":"12","author":"Jearth","year":"2022","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2024.101474_bib14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12664-021-01209-0","article-title":"Profile of patients with hepatocellular carcinoma: an experience from a tertiary care center in India","volume":"41","author":"Musunuri","year":"2022","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2024.101474_bib15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s12664-022-01314-8","article-title":"Kerala Hepatocellular Carcinoma Study Group. Multi-center prospective survey of hepatocellular carcinoma in Kerala: more than 1,200 cases","volume":"42","author":"Koshy","year":"2023","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2024.101474_bib16","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s12072-023-10498-w","article-title":"Etiologic fractions in patients of hepatocellular carcinoma in India with and without a background of cirrhosis: a multi-centric study","volume":"17","author":"Prabhakar","year":"2023","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2024.101474_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2024.101391","article-title":"Changing etiological spectrum of hepatocellular carcinoma in India - a systematic review and meta-analysis","volume":"14","author":"Giri","year":"2024","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2024.101474_bib18","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s12664-022-01289-6","article-title":"A\u00a0study of the clinical profile, predictors, prognostic features, and survival of patients with hepatocellular carcinoma having macroscopic portal vein tumor thrombosis","volume":"41","author":"Jearth","year":"2022","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2024.101474_bib19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000231886","article-title":"Clinical profile, etiology and therapeutic outcome in 324 hepatocellular carcinoma patients at a tertiary care center in India","volume":"77","author":"Paul","year":"2009","journal-title":"Oncology"},{"key":"10.1016\/j.jceh.2024.101474_bib20","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/gut.2003.020263","article-title":"Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications","volume":"53","author":"Benvegn\u00f9","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2024.101474_bib21","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1053\/j.gastro.2010.12.032","article-title":"Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection","volume":"140","author":"Kanwal","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2024.101474_bib22","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1572-0241.2002.05557.x","article-title":"Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience)","volume":"97","author":"Trevisani","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2024.101474_bib23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00432-004-0552-0","article-title":"Randomized controlled trial of screening for hepatocellular carcinoma","volume":"130","author":"Zhang","year":"2004","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.jceh.2024.101474_bib24","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.101474_bib25","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1136\/gut.2010.230508","article-title":"Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA","volume":"60","author":"El-Serag","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2024.101474_bib26","article-title":"2023 update of Indian national association for study of the liver consensus on management of intermediate and advanced hepatocellular carcinoma: the Puri III recommendations","volume":"14","author":"Kumar","year":"2024","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2024.101474_bib27","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/sj.bjc.6604301","article-title":"Surveillance of cirrhosis for hepatocellular carcinoma: a cost-utility analysis","volume":"98","author":"Thompson","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jceh.2024.101474_bib28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000343842","article-title":"Early hepatocellular carcinoma: definition and diagnosis","volume":"2","author":"Kudo","year":"2013","journal-title":"Liver Cancer"},{"issue":"suppl 19","key":"10.1016\/j.jceh.2024.101474_bib29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s00535-008-2274-6","article-title":"Multistep human hepatocarcinogenesis: correlation of imaging with pathology","volume":"44","author":"Kudo","year":"2009","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jceh.2024.101474_bib30","series-title":"General Rules for the Clinical and Pathological Study of Primary Liver Cancer","first-page":"27","year":"2019"},{"key":"10.1016\/j.jceh.2024.101474_bib31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000530079","article-title":"Surveillance, diagnosis, and treatment outcome of hepatocellular carcinoma in Japan: 2023 update","volume":"12","author":"Kudo","year":"2023","journal-title":"Liver Cancer"},{"key":"10.1016\/j.jceh.2024.101474_bib32","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101474_bib33","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.101474_bib34","doi-asserted-by":"crossref","first-page":"174","DOI":"10.7326\/0003-4819-131-3-199908030-00003","article-title":"Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis in Japan","volume":"131","author":"Yoshida","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jceh.2024.101474_bib35","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.cgh.2008.08.005","article-title":"Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis","volume":"6","author":"Andersson","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.101474_bib36","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0168-8278(03)00349-0","article-title":"Screening for hepatocellular carcinoma in cirrhosis","volume":"39","author":"Bolondi","year":"2003","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.101474_bib37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2036.2009.04014.x","article-title":"Metaanalysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis","volume":"30","author":"Singal","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2024.101474_bib38","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.21037\/qims.2019.10.04","article-title":"Surveillance of hepatocellular carcinoma by medical imaging","volume":"9","author":"Dietrich","year":"2019","journal-title":"Quant Imaging Med Surg"},{"key":"10.1016\/j.jceh.2024.101474_bib39","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3348\/kjr.2023.0324","article-title":"Diagnosing hepatocellular carcinoma using Sonazoid contrast-enhanced ultrasonography: 2023 guidelines from the Korean society of radiology and the Korean society of abdominal radiology","volume":"24","author":"Jeong","year":"2023","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.jceh.2024.101474_bib40","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jhep.2005.03.019","article-title":"Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial","volume":"43","author":"Di Bisceglie","year":"2005","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.101474_bib41","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1111\/hepr.12201","article-title":"Diagnostic accuracy of des-gamma-carboxy prothrombin versus alpha-fetoprotein for hepatocellular carcinoma: a systematic review","volume":"44","author":"Li","year":"2014","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jceh.2024.101474_bib42","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.cgh.2006.12.005","article-title":"The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population","volume":"5","author":"Leerapun","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.101474_bib43","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","article-title":"Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update","volume":"11","author":"Omata","year":"2017","journal-title":"Hepatol Int"},{"issue":"suppl 3","key":"10.1016\/j.jceh.2024.101474_bib44","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jceh.2014.04.003","article-title":"The Indian National Association for Study of the Liver (INASL) consensus on prevention, diagnosis and management of hepatocellular carcinoma in India: the Puri recommendations","volume":"4","author":"Kumar","year":"2014","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2024.101474_bib45","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jceh.2019.09.007","article-title":"2019 Update of Indian national association for study of the liver consensus on prevention, diagnosis, and management of hepatocellular carcinoma in India: the puri II recommendations","volume":"10","author":"Kumar","year":"2020","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2024.101474_bib46","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000514174","article-title":"Management of hepatocellular carcinoma in Japan: JSH consensus statements and recommendations 2021 update","volume":"10","author":"Kudo","year":"2021","journal-title":"Liver Cancer"},{"key":"10.1016\/j.jceh.2024.101474_bib47","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/hepr.13612","article-title":"Report of the 21st nationwide follow-up survey of primary liver cancer in Japan (2010-2011)","volume":"51","author":"Kudo","year":"2021","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jceh.2024.101474_bib48","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/liv.13096","article-title":"Regional differences in sorafenib-treated patients with hepatocellular carcinoma: GIDEON observational study","volume":"36","author":"Kudo","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2024.101474_bib49","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/hepr.13892","article-title":"Clinical practice guidelines for hepatocellular carcinoma: the Japan Society of Hepatology 2021 version (5th JSH-HCC guidelines)","volume":"53","author":"Hasegawa","year":"2023","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jceh.2024.101474_bib50","doi-asserted-by":"crossref","first-page":"30","DOI":"10.14309\/ajg.0000000000002572","article-title":"ACG clinical guideline: alcohol-associated liver disease","volume":"119","author":"Jophlin","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2024.101474_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001624","article-title":"Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis","volume":"11","author":"Singal","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.jceh.2024.101474_bib52","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/hep.23615","article-title":"Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States","volume":"52","author":"Davila","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101474_bib53","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.23504","article-title":"Barriers to surveillance for hepatocellular carcinoma in a multicenter cohort","volume":"5","author":"Parikh","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jceh.2024.101474_bib54","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/cld.1125","article-title":"Chronic hepatitis B: challenges and successes in India","volume":"18","author":"Premkumar","year":"2021","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10.1016\/j.jceh.2024.101474_bib56","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/hep.32341","article-title":"HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: a meta-analysis","volume":"76","author":"Lockart","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101474_bib57","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jhep.2021.11.025","article-title":"HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease","volume":"76","author":"Semmler","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.101474_bib58","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jhep.2019.10.005","article-title":"Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals","volume":"72","author":"Pons","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.101474_bib59","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.15626","article-title":"Assessment of a deep learning model to predict hepatocellular carcinoma in patients with hepatitis C cirrhosis","volume":"3","author":"Ioannou","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jceh.2024.101474_bib60","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.4254\/wjh.v13.i12.2039","article-title":"Deep learning in hepatocellular carcinoma: current status and future perspectives","volume":"13","author":"Ahn","year":"2021","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2024.101474_bib61","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-154-2-201101180-00006","article-title":"Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States","volume":"154","author":"Davila","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jceh.2024.101474_bib62","unstructured":"Available from: https:\/\/worldgastroenterology.org\/education-and-training\/train-the-trainers\/program-overview. Program Overview|World Gastroenterology Organisation."},{"key":"10.1016\/j.jceh.2024.101474_bib63","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.3390\/cancers13092251","article-title":"The Hepatic Innovation Team Collaborative: a successful population-based approach to hepatocellular carcinoma surveillance","volume":"13","author":"Rogal","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jceh.2024.101474_bib65","author":"Rao"},{"key":"10.1016\/j.jceh.2024.101474_bib66","unstructured":"Available from: https:\/\/india.asa-international.com\/responsibility\/vaccination-program."},{"key":"10.1016\/j.jceh.2024.101474_bib67","author":"Heijnen"},{"key":"10.1016\/j.jceh.2024.101474_bib68","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cgh.2022.01.047","article-title":"The performance of AFP, AFP-3, DCP as biomarkers for detection of hepatocellular carcinoma (HCC): a phase 3 biomarker study in the United States","volume":"21","author":"Tayob","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.101474_bib69","article-title":"Evaluation of the combined application of AFP, AFP-L3%, and DCP for hepatocellular carcinoma diagnosis: a meta-analysis","volume":"17","author":"Wang","year":"2020","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jceh.2024.101474_bib70","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3109\/00365521.2015.1082190","article-title":"Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients","volume":"51","author":"Lim","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jceh.2024.101474_bib71","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1349-7006.2011.01875.x","article-title":"Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein <20 ng\/mL","volume":"102","author":"Toyoda","year":"2011","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jceh.2024.101474_bib72","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.3748\/wjg.v21.i13.3928","article-title":"Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma","volume":"21","author":"Seo","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2024.101474_bib73","first-page":"1296","article-title":"The GALAD scoring algorithm based on AFP, AFP-L3, and DCP significantly improves detection of BCLC early stage hepatocellular carcinoma","volume":"54","author":"Best","year":"2016","journal-title":"Z\u00a0Gastroenterol"},{"key":"10.1016\/j.jceh.2024.101474_bib74","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep4.1847","article-title":"Multimarker panels for detection of early stage hepatocellular carcinoma: a prospective, multicenter, case-control study","volume":"6","author":"Piratvisuth","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jceh.2024.101474_bib75","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1158\/1055-9965.EPI-13-0870","article-title":"The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers","volume":"23","author":"Johnson","year":"2014","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.jceh.2024.101474_bib76","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.32185","article-title":"GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis","volume":"75","author":"Singal","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101474_bib77","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2147\/JHC.S271790","article-title":"Validation of the GALAD model and establishment of GAAP model for diagnosis of hepatocellular carcinoma in Chinese patients","volume":"7","author":"Liu","year":"2020","journal-title":"J\u00a0Hepatocell Carcinoma"},{"key":"10.1016\/j.jceh.2024.101474_bib78","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000317","article-title":"Development and clinical validation of a novel algorithmic score (GAAD) for detecting HCC in prospective cohort studies","volume":"7","author":"Piratvisuth","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jceh.2024.101474_bib79","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/liv.15082","article-title":"Validation of the GALAD model for early diagnosis and monitoring of hepatocellular carcinoma in Chinese multicenter study","volume":"42","author":"Huang","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2024.101474_bib80","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.jval.2022.09.337","article-title":"EE85 cost-effectiveness analysis of GAAD algorithm on the detection of early-stage hepatocellular carcinoma in patients with chronic liver disease in China","volume":"25","author":"Chen","year":"2022","journal-title":"Value Health"},{"key":"10.1016\/j.jceh.2024.101474_bib81","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.14309\/ajg.0000000000000715","article-title":"Cost-effectiveness of hepatocellular carcinoma surveillance: an assessment of benefits and harms","volume":"115","author":"Parikh","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2024.101474_bib82","doi-asserted-by":"crossref","first-page":"7303","DOI":"10.4103\/jfmpc.jfmpc_1140_22","article-title":"Status of cancer screening in India: an alarm signal from the National Family Health Survey (NFHS-5)","volume":"11","author":"Gopika","year":"2022","journal-title":"J\u00a0Family Med Prim Care"},{"key":"10.1016\/j.jceh.2024.101474_bib83","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1186\/2193-1801-3-610","article-title":"HCC surveillance results in earlier HCC detection: results from an Indian cohort","volume":"3","author":"Kohli","year":"2014","journal-title":"SpringerPlus"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688324001312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688324001312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T16:21:30Z","timestamp":1730910090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688324001312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":81,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0973688324001312"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2024.101474","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Redefining HCC Surveillance in India: A Call for Innovative and Inclusive Strategies","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2024.101474","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101474"}}